A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda. Odongpiny EAL, Nicol M, Katana E, Owori J, et al. HIV Med 2025 Jan 24. doi: 10.1111/hiv.13761.

Read + Share

Amedeo Smart

Independent Medical Education

Odongpiny EAL, Nicol M, Katana E, Owori J, et al. A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda. HIV Med 2025 Jan 24. doi: 10.1111/hiv.13761.
PMID: 39853832